{"url":"https://lda.senate.gov/api/v1/filings/80da2f9f-861e-4e00-869b-0add108e0bb0/","filing_uuid":"80da2f9f-861e-4e00-869b-0add108e0bb0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/80da2f9f-861e-4e00-869b-0add108e0bb0/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Daniel Skallman","dt_posted":"2024-07-22T14:47:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1901 Pennsylvania Ave, NW","registrant_address_2":"Suite 1003","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401104645,"url":"https://lda.senate.gov/api/v1/registrants/401104645/","house_registrant_id":null,"name":"CEPI-U.S.","description":"Advocacy and education on behalf of CEPI Norway","address_1":"1901 Pennsylvania Ave, NW","address_2":"Suite 1003","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DANIEL SKALLMAN","contact_telephone":"+1 202-809-6763","dt_updated":"2026-07-27T16:24:38.997168-04:00"},"client":{"id":202185,"url":"https://lda.senate.gov/api/v1/clients/202185/","client_id":12,"name":"CEPI-U.S.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-05-24"},"lobbying_activities":[{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"Education and advocacy supporting the funding and mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines and other countermeasures for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R. 4665, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024, Title III, provisions relating to global health programs and global health security; Title VII, provisions relating to pandemic preparedness and response S. 2438, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024, Title III, provisions relating to global health programs and global health security H.R.8771, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, Title III, provisions relating to global health programs and global health security Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, provisions relating to global health programs and global health security (no bill number as of filing)","foreign_entity_issues":"The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines and other countermeasures against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.","lobbyists":[{"lobbyist":{"id":112566,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"SKALLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":203,"name":"Overseas Private Investment Corp (OPIC)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":196,"name":"U.S. Agency for International Development (USAID)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Education and advocacy supporting the funding and mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines and other countermeasures for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R. 4665, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024, Title III, provisions relating to global health programs and global health security; Title VII, provisions relating to pandemic preparedness and response S. 2438, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024, Title III, provisions relating to global health programs and global health security H.R.8771, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, Title III, provisions relating to global health programs and global health security. Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, provisions relating to global health programs and global health security (no bill number as of filing)","foreign_entity_issues":"The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines and other countermeasures against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.","lobbyists":[{"lobbyist":{"id":112566,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"SKALLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":196,"name":"U.S. Agency for International Development (USAID)"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS","contribution":"50000.00","ownership_percentage":"100.00","address":"Skoyen Atrium, Askekroken 11, 0277","city":"Oslo","state":null,"state_display":null,"country":"NO","country_display":"Norway","ppb_city":"Oslo","ppb_state":null,"ppb_state_display":null,"ppb_country":"NO","ppb_country_display":"Norway"}],"affiliated_organizations":[]}